During the last session, ASLAN Pharmaceuticals Ltd ADR (NASDAQ:ASLN)’s traded shares were 1.01 million, with the beta value of the company hitting 1.51. The 52-week high for the ASLN share is $4.69, that puts it down -897.87 from that peak though still a striking 17.02% gain since the share price plummeted to a 52-week low of $0.39. The company’s market capitalization is $8.27M, and the average trade volume was 1.19 million shares over the past three months.
ASLAN Pharmaceuticals Ltd ADR (NASDAQ:ASLN) trade information
ASLAN Pharmaceuticals Ltd ADR (ASLN) registered a 0.21% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.21% in intraday trading to $0.47, hitting a weekly high. The stock’s 5-day price performance is -4.28%, and it has moved by -28.06% in 30 days. Based on these gigs, the overall price performance for the year is -88.81%.
ASLAN Pharmaceuticals Ltd ADR (ASLN) estimates and forecasts
Statistics show that ASLAN Pharmaceuticals Ltd ADR has underperformed its competitors in share price, compared to the industry in which it operates. ASLAN Pharmaceuticals Ltd ADR (ASLN) shares have gone down -59.83% during the last six months, with a year-to-date growth rate less than the industry average at 0.00% against 12.90. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 52.70% this quarter and then drop -390.90% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.51%. While earnings are projected to return 31.41% in 2024.
ASLN Dividends
ASLAN Pharmaceuticals Ltd ADR is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
